Thursday, March 23, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

Host Response Profiling of Burkholderia, Y. Pestis

by Global Biodefense Staff
January 5, 2015
Gram Negative Burkholderia pseudomallei

Gram-negative Burkholderia pseudomallei bacteria, which was grown on a medium of sheep’s blood agar for 72 hours. Background image credit: Dr. Todd Parker/CDC

The U.S. Medical Research Institute of lnfectious Diseases (USAMRIID) has announced intentions to award a new contract to George Mason University for profiling of host responses to high priority pathogens.

The required services include profiling of Intracellular Signaling utilizing Reverse Phase Protein Microarray (RPMA) technology for phosphoproteomic profiling of target host proteins that are significantly affected during infection with isolates of Burkholderia species; and to perform the functional characterization of select host targets that are identified through RPMA.

In addition, George Mason University will be required to perform functional characterizations of select Yersinia pestis host targets identified through RPMA analysis.

Intercellular Signaling tasks under the contract include comprehensive analysis of the mechanisms of exosome-based intercellular communication during infection with Y. pestis and also other biodefense agents using different methodologies, including RPAM and mass spectrometry analysis.

“George Mason University has extensive experience performing this type of highly complex, specialized research and with the particular scientific questions of this requirement,” states the announcement.

The estimated total value of this contract, including its proposed two one-year option periods, is $340,000.

Tags: AwardsBurkholderiaImmune ResponseUSAMRIIDY. pestis

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC